The two are hot topics, but how do they combine in the arena of HIV? That's what two lectures at Grand Valley State University's Allendale Campus will explore on April 13. The first lecture is by ...

Vaccine development remains central to reducing incident HIV globally, particularly where long-acting PrEP access is limited, with therapeutic and preventive approaches advancing in parallel.

The running themes of treating and preventing HIV will be highlighted early in the plenary session held on Monday morning. Ilesh Jani from the Mozambique National Institute of Health in Maputo, ...

Overall, the story of HIV is one of astounding success. But to declare victory, it will be necessary to develop a vaccine. The opening session of the 31st Conference on Retroviruses and Opportunistic ...

Dr. Anthony Fauci detailed his extensive career leading the U.S. through multiple health crises in his role as the director of the National Institute of Allergy and Infectious Diseases and emphasized ...

The United States is retreating from its global leadership role in infectious disease control. Correction, April 10: This article has been updated to clarify differences between the once-yearly and ...